Algert Global LLC Sells 1,070 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS)

Algert Global LLC cut its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 6.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 15,278 shares of the company’s stock after selling 1,070 shares during the quarter. Algert Global LLC’s holdings in Nu Skin Enterprises were worth $865,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Eagle Bay Advisors LLC acquired a new stake in Nu Skin Enterprises in the 2nd quarter valued at about $40,000. Optimum Investment Advisors acquired a new stake in shares of Nu Skin Enterprises in the second quarter valued at approximately $48,000. Rockefeller Capital Management L.P. boosted its position in Nu Skin Enterprises by 19,862.5% in the 1st quarter. Rockefeller Capital Management L.P. now owns 1,597 shares of the company’s stock valued at $84,000 after buying an additional 1,589 shares during the last quarter. AGF Investments LLC acquired a new stake in shares of Nu Skin Enterprises in the 1st quarter valued at $87,000. Finally, Centaurus Financial Inc. bought a new stake in shares of Nu Skin Enterprises during the second quarter worth $101,000. Institutional investors and hedge funds own 81.06% of the company’s stock.

NYSE:NUS traded up $0.18 on Thursday, hitting $40.89. The company’s stock had a trading volume of 1,062 shares, compared to its average volume of 495,386. The company has a current ratio of 1.56, a quick ratio of 0.93 and a debt-to-equity ratio of 0.31. Nu Skin Enterprises, Inc. has a one year low of $39.40 and a one year high of $63.85. The stock has a fifty day moving average of $46.96 and a two-hundred day moving average of $52.93. The firm has a market capitalization of $2.05 billion, a P/E ratio of 8.97 and a beta of 1.15.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Wednesday, August 4th. The company reported $1.15 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.06 by $0.09. The company had revenue of $704.10 million for the quarter, compared to analyst estimates of $703.38 million. Nu Skin Enterprises had a net margin of 8.35% and a return on equity of 26.95%. The company’s revenue was up 15.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.81 earnings per share. As a group, sell-side analysts anticipate that Nu Skin Enterprises, Inc. will post 4.42 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 8th. Shareholders of record on Friday, August 27th were paid a $0.38 dividend. This represents a $1.52 annualized dividend and a yield of 3.72%. The ex-dividend date of this dividend was Thursday, August 26th. Nu Skin Enterprises’s dividend payout ratio (DPR) is 41.87%.

A number of analysts recently commented on the company. Citigroup lowered their price objective on Nu Skin Enterprises from $59.00 to $43.00 and set a “neutral” rating for the company in a research report on Tuesday. Tigress Financial reissued a “buy” rating and issued a $72.00 target price on shares of Nu Skin Enterprises in a research note on Friday, October 1st. TheStreet cut Nu Skin Enterprises from a “b-” rating to a “c+” rating in a research note on Friday, October 8th. Zacks Investment Research downgraded shares of Nu Skin Enterprises from a “buy” rating to a “sell” rating and set a $43.00 price target on the stock. in a research report on Friday, October 8th. Finally, DA Davidson decreased their price objective on shares of Nu Skin Enterprises from $61.00 to $47.00 and set a “neutral” rating for the company in a report on Wednesday, October 6th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $55.83.

In related news, EVP Joseph Y. Chang sold 16,000 shares of Nu Skin Enterprises stock in a transaction that occurred on Monday, September 13th. The shares were sold at an average price of $47.41, for a total value of $758,560.00. Following the transaction, the executive vice president now directly owns 33,942 shares of the company’s stock, valued at $1,609,190.22. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Jeffrey Clark Bettinger sold 1,625 shares of the business’s stock in a transaction on Tuesday, October 5th. The stock was sold at an average price of $41.10, for a total value of $66,787.50. The disclosure for this sale can be found here. Insiders own 4.00% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes personal care products and nutritional supplements. The firm engages in the provision of beauty and wellness products and solutions. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J.

Featured Article: What is the Quick Ratio?

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.